| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
27 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-11-17 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
The Update on the Commercial Rollout of CompuFlo Epidural System and CathCheck in
the Third Quarter of 202
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_
today provided an update on commercial rollout of CompuFlo® Epidural System and CathCheck™
in the third quarter ended September 30, 2020.
With a number of hospitals re-opening to outside vendors, the Company is advancing
its sales efforts and exploring new collaboration opportunities around the CompuFlo®
Epidural System and CathCheck™. Most recently, the Issuer was awarded a group purchasing
agreement with Premier, a leading group purchasing organization, with approximately
4,100 U.S. hospitals and 200,000 other providers within their network. This agreement
is further validation of the growing awareness and importance of its instruments in
improving health outcomes and lowering costs for healthcare institutions. At the same
time, the Company is expanding its trials in major hospitals and medical schools,
as well as partnering with key opinion leaders to approach the purchasing departments
of hospitals together. The Board of Directors of the Company looks forward to announcing
additional agreements with several premier hospitals as soon as they are completed.
The Board of Directors of the Company believes that the financing from its parent
raised last quarter will support its ongoing activities, including accelerated marketing
activities around its medical instruments.
|
|
|
RB_ASO: The Update on the Commercial Rollout of CompuFlo Epidural System and CathCheck in
the Third Quarter of 202
